User profiles for M.R. Wilkins

Marc Wilkins

- Verified email at unsw.edu.au - Cited by 33908

Martin Wilkins

- Verified email at imperial.ac.uk - Cited by 24253

[BOOK][B] Protein identification and analysis tools on the ExPASy server

…, C Hoogland, A Gattiker, S Duvaud, MR Wilkins… - 2005 - Springer
Protein identification and analysis software performs a central role in the investigation of
proteins from two-dimensional (2-D) gels and mass spectrometry. For protein identification, the …

Definitions and diagnosis of pulmonary hypertension

…, A Manes, T Satoh, F Torres, MR Wilkins… - Journal of the American …, 2013 - jacc.org
Wilkins has received speaker and/or consulting fees from Bayer, GlaxoSmithKline, Pfizer,
and Novartis; and has received research funding from the British Heart Foundation, Wellcome …

[PDF][PDF] Progress with proteome projects: why all proteins expressed by a genome should be identified and how to do it

MR Wilkins, JC Sanchez, AA Gooley… - Biotechnology and …, 1996 - Taylor & Francis
The advent of large genolne sequencing projects has changed the scale of biology. Over a
relatively short period of tinle, we have witnessed the elucidation of the conlplete nucleotide …

Progress with gene‐product mapping of the Mollicutes: Mycoplasma genitalium

…, JX Yan, AA Gooley, MR Wilkins… - …, 1995 - Wiley Online Library
A protein map of the smallest known self‐replicating organism, Mycoplasma genitalium (Class:
Mollicutes), revealed a high proportion of acidic proteins. Amino acid composition was …

From proteins to proteomes: large scale protein identification by two-dimensional electrophoresis and arnino acid analysis

MR Wilkins, C Pasquali, RD Appel, K Ou, O Golaz… - Bio/technology, 1996 - nature.com
Separation and identification of proteins by two-dimensional (2-D) electrophoresis can be
used for protein-based gene expression analysis. In this report single protein spots, from …

[HTML][HTML] Riociguat for the treatment of chronic thromboembolic pulmonary hypertension

…, E Mayer, G Simonneau, MR Wilkins… - … England Journal of …, 2013 - Mass Medical Soc
Background Riociguat, a member of a new class of compounds (soluble guanylate cyclase
stimulators), has been shown in previous clinical studies to be beneficial in the treatment of …

[HTML][HTML] Mechanisms of disease: pulmonary arterial hypertension

RT Schermuly, HA Ghofrani, MR Wilkins… - Nature Reviews …, 2011 - nature.com
Our understanding of, and approach to, pulmonary arterial hypertension has undergone a
paradigm shift in the past decade. Once a condition thought to be dominated by increased …

Sildenafil inhibits hypoxia-induced pulmonary hypertension

…, A Maripov, MM Mirrakhimov, A Aldashev, MR Wilkins - Circulation, 2001 - Am Heart Assoc
Background This study investigated the effect of the phosphodiesterase 5 inhibitor sildenafil
on the pulmonary vascular response to hypoxia in humans and mice. Methods and Results …

The minimum information about a proteomics experiment (MIAPE)

…, TM Vondriska, JP Whitelegge, MR Wilkins… - Nature …, 2007 - nature.com
Both the generation and the analysis of proteomics data are now widespread, and high-throughput
approaches are commonplace. Protocols continue to increase in complexity as …

Basic science of pulmonary arterial hypertension for clinicians: new concepts and experimental therapies

SL Archer, EK Weir, MR Wilkins - Circulation, 2010 - Am Heart Assoc
… Dr Wilkins is supported by grants from the British Heart Foundation and Medical Research
Council. All authors had full access to the manuscript and approved the final version. …